This morning, Medtronic Diabetes announced FDA approval and U.S. market launch of its long-awaited mySentry Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm REAL-Time Revel System…
SOURCE: Healthline RSS Feed – Read entire story here.